2006
DOI: 10.1111/j.1574-695x.1997.tb01085.x
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of the human Ig isotype response to individual transferrin binding proteins A and B from Neisseria meningitidis

Abstract: Subcapsular antigens, including transferrin binding proteins, are being considered as potential vaccines against serogroup B meningococci. This study examined the human isotype antibody responses in cases of meningococcal disease to meningococcal TbpA (transferrin binding protein A) and TbpB (transferrin binding protein B) from two strains (SD and B16B6) expressing high and low molecular mass TbpB respectively. TbpA isolated from both strains were recognised more frequently and higher durable ELISA absorbance … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…that TbpB should be considered as a candidate for a possible vaccine against N. meningitidis infection (1)(2)(3)19). TbpB antibodies can be measured in convalescent-phase sera from patients with meningococcal disease (18,19,22); they are protective in a mouse model of infection, and they are also bactericidal in laboratory animals (24). However, TbpB is highly variable in different strains of N. gonorrhoeae and, taken together with lower tbpB transcript amounts produced in subject samples, may explain why we observed lower titers of IgG antibody against TbpB antigen than against TbpA.…”
Section: Discussionmentioning
confidence: 99%
“…that TbpB should be considered as a candidate for a possible vaccine against N. meningitidis infection (1)(2)(3)19). TbpB antibodies can be measured in convalescent-phase sera from patients with meningococcal disease (18,19,22); they are protective in a mouse model of infection, and they are also bactericidal in laboratory animals (24). However, TbpB is highly variable in different strains of N. gonorrhoeae and, taken together with lower tbpB transcript amounts produced in subject samples, may explain why we observed lower titers of IgG antibody against TbpB antigen than against TbpA.…”
Section: Discussionmentioning
confidence: 99%
“…TbpA is currently being considered as a candidate for inclusion in a meningococcal vaccine effective against all serogroups. Recombinant TbpA produces a strong immunogenic response in mice, protecting them from subsequent intraperitoneal challenge with N.meningitidis (West et al, 2001), while antibodies in sera from diseased patients cross-react with a range of meningococcal isolates (Gorringe et al, 1995;Johnson et al, 1997). TbpB displays greater sequence heterogeneity between strains and ranges in molecular weight from 65 to 85 kDa.…”
Section: Introductionmentioning
confidence: 99%